<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The study was carried out to see prevalence of <z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">Kidney Disease</z:e> (CKD) specific <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> and cardiovascular events among patients with <z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">Kidney Disease</z:e> stage-V (CKD-V) before starting dialysis therapy in the department of Nephrology of National Institute of <z:e sem="disease" ids="C0022658" disease_type="Disease or Syndrome" abbrv="">Kidney Diseases</z:e> &amp; Urology (NIKDU), Dhaka, Bangladesh </plain></SENT>
<SENT sid="1" pm="."><plain>Among CKD specific <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e>, <z:hpo ids='HP_0001903'>anemia</z:hpo> showed the highest prevalence (96.7%) in study population </plain></SENT>
<SENT sid="2" pm="."><plain>More than fifty percent of CKD-V patients had both <z:hpo ids='HP_0002901'>hypocalcaemia</z:hpo> and <z:e sem="disease" ids="C0085681" disease_type="Disease or Syndrome" abbrv="">hyperphosphataemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="9679">Calcium-Phosphate</z:chebi> Product (CaXP) was elevated among 23 percent of the population </plain></SENT>
<SENT sid="4" pm="."><plain>C-reactive protein, an <z:hpo ids='HP_0011009'>acute</z:hpo> phase protein was positive in 78% of CKD-V patients </plain></SENT>
<SENT sid="5" pm="."><plain>Besides, among traditional risk factors, <z:hpo ids='HP_0000822'>Hypertension</z:hpo> and <z:hpo ids='HP_0000819'>Diabetes Mellitus</z:hpo> were present in 83.3% and 23% of the study population respectively </plain></SENT>
<SENT sid="6" pm="."><plain>The prevalence of cardiovascular events among CKD-V patients showed that 18.3% had <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e>, 38% <z:hpo ids='HP_0001635'>heart failure</z:hpo>, 4.7% <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> and 9% <z:hpo ids='HP_0001712'>left ventricular hypertrophy</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Females were significantly prone to develop cardiovascular events than their male counterpart (p=0.028) </plain></SENT>
<SENT sid="8" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp> was significantly higher in patients with cardiovascular complications than in patients without cardiovascular complications (p=0.021) </plain></SENT>
</text></document>